Balance Sheet

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 16,522 $ 7,082
Note receivable - LINICO 600 0
Accounts receivable 67 12
Lease receivable 0 15,527
Inventory 929 278
Assets held for sale 0 47
Prepaid expenses and other current assets 181 263
Total current assets 18,299 23,209
Non-current assets    
Property, plant and equipment, net 10,347 7,343
Intellectual property, net 281 461
Investment in LINICO 0 2,000
Other assets 4,673 489
Total non-current assets 15,301 10,293
Total assets 33,600 33,502
Current liabilities    
Accounts payable 1,836 1,075
Accrued Expenses 2,467 1,780
Building purchase deposit 0 3,250
Lease liability, current portion 275 307
Note payable, current portion 35 5,899
Total current liabilities 4,613 12,311
Lease liability, non-current portion 0 275
Note payable, non-current portion 2,923 0
Total liabilities 7,536 12,586
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Common stock; $0.001 par value; 200,000,000 shares authorized; 108,308,661 and 107,880,095, shares issued and outstanding as of December 31, 2023, respectively and 79,481,751 shares issued and outstanding as of December 31, 2022 108 79
Additional paid-in capital 249,687 220,114
Accumulated deficit (223,215) (199,277)
Treasury stock, at cost; common shares: 428,566 and nil as of December 31, 2023 and December 31, 2022, respectively (516) 0
Total stockholders’ equity 26,064 20,916
Total liabilities and stockholders’ equity $ 33,600 $ 33,502

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL